Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Clinical trial NCT01601704 · TERMINATED
Trial details
- NCT number
- NCT01601704
- Sponsor
- Orexigen Therapeutics, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-08-01
- Enrollment
- 8910
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.